G-PROTEIN EFFECTORS AS TARGETS FOR ANTINEOPLASTIC THERAPIES
G 蛋白效应物作为抗肿瘤治疗的靶点
基本信息
- 批准号:3774670
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:3T3 cells G protein antineoplastics arachidonate biological signal transduction bombesin breast neoplasms calcium flux cell growth regulation cell membrane enzyme activity growth factor receptors guanosinetriphosphatases human tissue lactate dehydrogenases lung neoplasms membrane proteins molecular cloning neoplasm /cancer chemotherapy neoplastic cell neuropeptides phospholipase C prostate neoplasms protein structure function thiophosphate
项目摘要
Bombesin-like peptides have been implicated as growth factors for certain
lung, breast, and prostate carcinoma cells. These peptides are known to
transduce growth regulatory signals through guanine nucleotide binding
proteins(G-proteins) to such effectors as phospholipases. Due to the
heterogeneity of growth factor receptor expression, it is possible that
the optimal therapeutic manipulation of this system will occur at the
post-receptor level. In an effort to disrupt the interaction of G-
protein-coupled receptors such as the Gastrin-releasing peptide (GRP) and
neuromedia B (NMB) peptides were synthesized based on mastoparan, a wasp
venom toxin known to interact with and stimulate the GTPase activity of
the Gi family of G-proteins. Structure activity analysis of this series
revealed that cell growth was inhibited by peptides which retain a
spacing of charge and amphilicity similar to the parent compound. Merely
producing peptides with alpha-helical content or with positive charge did
not allow cytotoxicity to occur. Evidence of membrane disruption with
release of lactate dehydrogenase and increase of intracellular calcium
concentration appeared to occur at cytotoxic concentrations. Therefore,
mastoparan-like peptides appear to mediate growth inhibition of the lung
tumor and Swiss 3T3 cells by a membrane cytolytic effect rather than
discrete regulation of known G-protein-coupled effectors. Further
studies will define in subcellular factions whether these peptides can
regulate discrete G-protein coupled effector systems. The results of
these studies may suggest lead structures for avoiding the membrane lytic
effect and regulating G-protein function.
蛙皮素样肽被认为是某些肿瘤的生长因子,
肺癌、乳腺癌和前列腺癌细胞。 已知这些肽
通过鸟嘌呤核苷酸结合的细胞生长调节信号
蛋白质(G蛋白)与磷脂酶等效应物的结合。 由于
由于生长因子受体表达的异质性,
该系统的最佳治疗操作将发生在
受体后水平。 为了破坏G-
蛋白偶联受体如胃泌素释放肽(GRP)和
以马蜂mastoparan为原料,合成了神经介质B(NMB)肽
已知与GT3相互作用并刺激GT3活性的毒液毒素
G蛋白的Gi家族 该系列的结构活性分析
揭示了细胞生长被肽抑制,
电荷间距和两亲性与母体化合物相似。 仅仅
产生具有α-螺旋含量或带正电荷的肽,
不允许发生细胞毒性。 膜破裂的证据,
乳酸脱氢酶的释放和细胞内钙的增加
浓度似乎发生在细胞毒性浓度。 因此,我们认为,
类乳突肽似乎介导肺的生长抑制
肿瘤和Swiss 3T3细胞通过膜细胞溶解作用,而不是
已知G蛋白偶联效应物的离散调节。 进一步
研究将在亚细胞中确定这些肽是否可以
调节离散的G蛋白偶联效应系统。 的结果
这些研究可能提出了避免膜溶解的铅结构
影响和调节G蛋白功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E SAUSVILLE其他文献
E SAUSVILLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E SAUSVILLE', 18)}}的其他基金
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
人类 SCLC 中的第二信使和受体系统
- 批准号:
3916617 - 财政年份:
- 资助金额:
-- - 项目类别:
SECOND MESSENGER AND RECEPTOR SYSTEMS IN HUMAN SCLC
人类 SCLC 中的第二信使和受体系统
- 批准号:
3939550 - 财政年份:
- 资助金额:
-- - 项目类别:
TOXINS TARGETED TO THE CELL MEMBRANE--DISRUPTION OF SIGNAL TRANSDUCTION
针对细胞膜的毒素——信号转导的破坏
- 批准号:
3752418 - 财政年份:
- 资助金额:
-- - 项目类别:
PRECLINICAL AND CLINICAL PHARMACOLOGY OF PROTEIN KINASE ANTAGONISTS
蛋白激酶拮抗剂的临床前和临床药理学
- 批准号:
3752419 - 财政年份:
- 资助金额:
-- - 项目类别:
PROTEIN KINASE ANTAGONISTS--PRECLINICAL AND CLINICAL STUDIES
蛋白激酶拮抗剂——临床前和临床研究
- 批准号:
2464490 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Intelligent cryo-electron microscopy of G protein-coupled receptors
G 蛋白偶联受体的智能冷冻电子显微镜
- 批准号:
23K23818 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cryo-electron microscopy determination of G protein-coupled receptor states
冷冻电镜测定 G 蛋白偶联受体状态
- 批准号:
DE230101681 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Discovery Early Career Researcher Award
RUI: Identifying reproductive roles for the Super-conserved Receptors Expressed in Brain (SREB) G protein-coupled receptor family using novel agonists and a comparative fish model
RUI:使用新型激动剂和比较鱼类模型确定脑中表达的超级保守受体 (SREB) G 蛋白偶联受体家族的生殖作用
- 批准号:
2307614 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
Development of multidrug combination molecular targeted therapeutics based on G protein-coupled receptor interactions in glioblastoma
基于G蛋白偶联受体相互作用的胶质母细胞瘤多药组合分子靶向治疗的开发
- 批准号:
23K08551 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of Intermediate Conformations in G Protein-coupled Receptor Signaling
中间构象在 G 蛋白偶联受体信号传导中的作用
- 批准号:
10635763 - 财政年份:2023
- 资助金额:
-- - 项目类别:
India Link: Selective interactions between G protein-coupled receptors and conformationally selective arrestin variants
India Link:G 蛋白偶联受体与构象选择性抑制蛋白变体之间的选择性相互作用
- 批准号:
BB/T018720/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant
Architecture of inhibitory G protein signaling in the hippocampus
海马抑制性 G 蛋白信号传导的结构
- 批准号:
10659438 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Molecular mechanisms of GPCR/G protein diseases and drug development
GPCR/G蛋白疾病的分子机制及药物开发
- 批准号:
23K07998 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research Initiation Award: Exploring Class A G-Protein Coupled Receptors (GPCRs)-Ligand Interaction through Machine Learning Approaches
研究启动奖:通过机器学习方法探索 A 类 G 蛋白偶联受体 (GPCR)-配体相互作用
- 批准号:
2300475 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant